|
Volumn 27, Issue 1 SUPPL. 2, 2000, Pages 33-35
|
Paclitaxel (Taxol) combination therapy for resistant germ cell tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
MESNA;
PACLITAXEL;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
GERM CELL TUMOR;
HUMAN;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SALVAGE THERAPY;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
GERMINOMA;
HUMANS;
MALE;
PACLITAXEL;
REMISSION INDUCTION;
SALVAGE THERAPY;
TESTICULAR NEOPLASMS;
|
EID: 0033969669
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (15)
|